Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial
Marinde J. G. Bond(Utrecht University), Cornelis J.A. Punt(Utrecht University), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Anne M. May(Utrecht University), Krijn P. van Lienden(University of Amsterdam), Karen Bolhuis(The Netherlands Cancer Institute), Marc Engelbrecht(University of Amsterdam), Clinton Mijnals(OLVG), M.J. van Amerongen(Sint Maartenskliniek), John J. Hermans(Erasmus MC)
Cited by 2
Related Papers
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788